TY - JOUR
T1 - Hippocampal sparing radiotherapy for pediatric medulloblastoma
T2 - impact of treatment margins and treatment technique
AU - Brodin, Nils Patrik
AU - Munck af Rosenschöld, Per
AU - Blomstrand, Malin
AU - Berthelsen, Anne Kiil
AU - Hollensen, Christian
AU - Vogelius, Ivan R.
AU - Lannering, Birgitta
AU - Bentzen, Søren M.
AU - Bjørk-Eriksson, Thomas
PY - 2014
Y1 - 2014
N2 - BackgroundWe investigated how varying the treatment margin and applying hippocampal sparing and proton therapy impact the risk of neurocognitive impairment in pediatric medulloblastoma patients compared with current standard 3D conformal radiotherapy.MethodsWe included 17 pediatric medulloblastoma patients to represent the variability in tumor location relative to the hippocampal region. Treatment plans were generated using 3D conformal radiotherapy, hippocampal sparing intensity-modulated radiotherapy, and spot-scanned proton therapy, using 3 different treatment margins for the conformal tumor boost. Neurocognitive impairment risk was estimated based on dose-response models from pediatric CNS malignancy survivors and compared among different margins and treatment techniques.ResultsMean hippocampal dose and corresponding risk of cognitive impairment were decreased with decreasing treatment margins (P
AB - BackgroundWe investigated how varying the treatment margin and applying hippocampal sparing and proton therapy impact the risk of neurocognitive impairment in pediatric medulloblastoma patients compared with current standard 3D conformal radiotherapy.MethodsWe included 17 pediatric medulloblastoma patients to represent the variability in tumor location relative to the hippocampal region. Treatment plans were generated using 3D conformal radiotherapy, hippocampal sparing intensity-modulated radiotherapy, and spot-scanned proton therapy, using 3 different treatment margins for the conformal tumor boost. Neurocognitive impairment risk was estimated based on dose-response models from pediatric CNS malignancy survivors and compared among different margins and treatment techniques.ResultsMean hippocampal dose and corresponding risk of cognitive impairment were decreased with decreasing treatment margins (P
U2 - 10.1093/neuonc/not225
DO - 10.1093/neuonc/not225
M3 - Journal article
C2 - 24327585
SN - 1522-8517
VL - 16
SP - 594
EP - 602
JO - Neuro-Oncology
JF - Neuro-Oncology
IS - 4
ER -